DK20489A - 1-heterocyclyl-1h-indazol-3-eddikesyre-forbindelser og farmaceutiske praeparater indeholdende disse eller tilsvarende 1-phenyl-forbindelser - Google Patents

1-heterocyclyl-1h-indazol-3-eddikesyre-forbindelser og farmaceutiske praeparater indeholdende disse eller tilsvarende 1-phenyl-forbindelser

Info

Publication number
DK20489A
DK20489A DK020489A DK20489A DK20489A DK 20489 A DK20489 A DK 20489A DK 020489 A DK020489 A DK 020489A DK 20489 A DK20489 A DK 20489A DK 20489 A DK20489 A DK 20489A
Authority
DK
Denmark
Prior art keywords
compounds
acetic acid
indazol
heterocyclyl
similar
Prior art date
Application number
DK020489A
Other languages
English (en)
Other versions
DK20489D0 (da
Inventor
Banavara Lakshman Mylari
William James Zembrowski
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of DK20489D0 publication Critical patent/DK20489D0/da
Publication of DK20489A publication Critical patent/DK20489A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Urology & Nephrology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
DK020489A 1988-01-19 1989-01-18 1-heterocyclyl-1h-indazol-3-eddikesyre-forbindelser og farmaceutiske praeparater indeholdende disse eller tilsvarende 1-phenyl-forbindelser DK20489A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US1988/000110 WO1989006651A1 (en) 1988-01-19 1988-01-19 1h-indazole-3-acetic acids as aldose reductase inhibitors

Publications (2)

Publication Number Publication Date
DK20489D0 DK20489D0 (da) 1989-01-18
DK20489A true DK20489A (da) 1989-07-20

Family

ID=22208496

Family Applications (1)

Application Number Title Priority Date Filing Date
DK020489A DK20489A (da) 1988-01-19 1989-01-18 1-heterocyclyl-1h-indazol-3-eddikesyre-forbindelser og farmaceutiske praeparater indeholdende disse eller tilsvarende 1-phenyl-forbindelser

Country Status (11)

Country Link
EP (1) EP0325375B1 (da)
JP (1) JPH0625136B2 (da)
AT (1) ATE79378T1 (da)
CA (1) CA1335733C (da)
DE (1) DE68902396T2 (da)
DK (1) DK20489A (da)
ES (1) ES2042988T3 (da)
FI (1) FI93834C (da)
IE (1) IE61943B1 (da)
PT (1) PT89469B (da)
WO (1) WO1989006651A1 (da)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4954629A (en) * 1989-05-11 1990-09-04 Pfizer Inc. Process and intermediates for the preparation of oxophthalazinyl acetic acids and analogs thereof
WO2012009553A1 (en) * 2010-07-16 2012-01-19 The Trustees Of Columbia University In The City Of New York Aldose reductase inhibitors and uses thereof
US8916563B2 (en) 2010-07-16 2014-12-23 The Trustees Of Columbia University In The City Of New York Aldose reductase inhibitors and uses thereof
CA3025081A1 (en) * 2016-06-21 2017-12-28 The Trustees Of Columbia University In The City Of New York Substituted 3,4-dihydrothieno [3,4-d]pyridazine compounds and use thereof as aldose reductase inhibitors
WO2019023648A1 (en) 2017-07-28 2019-01-31 Applied Therapeutics Inc. COMPOSITIONS AND METHODS FOR TREATING GALACTOSEMIA
BR112021019596A2 (pt) * 2019-04-01 2021-11-30 Applied Therapeutics Inc Inibidores de aldose redutase

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS4935269A (da) * 1972-08-05 1974-04-01
JPS5135269A (da) * 1974-09-20 1976-03-25 Hitachi Ltd
JPS58144374A (ja) * 1982-02-23 1983-08-27 Fujisawa Pharmaceut Co Ltd インダゾ−ル酢酸誘導体およびその製造法
JPS5998060A (ja) * 1982-11-27 1984-06-06 Fujisawa Pharmaceut Co Ltd インダゾ−ル誘導体、その製造法および農薬
DE3684410D1 (de) * 1985-11-07 1992-04-23 Pfizer Heterocyclische oxophthalazinylessigsaeure.
JPH0676391B2 (ja) * 1987-06-09 1994-09-28 フアイザー・インコーポレイテツド ベンゾチアゾール等の複素環側鎖を有するオキソフタラジニル酢酸類の製造方法

Also Published As

Publication number Publication date
ATE79378T1 (de) 1992-08-15
FI93834C (fi) 1995-06-12
EP0325375A1 (en) 1989-07-26
DE68902396T2 (de) 1992-12-10
FI93834B (fi) 1995-02-28
EP0325375B1 (en) 1992-08-12
CA1335733C (en) 1995-05-30
IE61943B1 (en) 1994-11-30
PT89469A (pt) 1990-02-08
DE68902396D1 (de) 1992-09-17
JPH01216975A (ja) 1989-08-30
FI903626A0 (fi) 1990-07-18
ES2042988T3 (es) 1993-12-16
JPH0625136B2 (ja) 1994-04-06
DK20489D0 (da) 1989-01-18
PT89469B (pt) 1993-12-31
IE890143L (en) 1989-07-19
WO1989006651A1 (en) 1989-07-27

Similar Documents

Publication Publication Date Title
NO894367L (no) System og fremgangsmaate for kvantitativ bestemmelse av konsentrasjonene av flere gasser i boreslam.
FI893433A (fi) Menetelmä terapeuttisesti käyttökelpoisten heterosyklisten yhdisteiden valmistamiseksi
DK166789D0 (da) Substituerede flavonoidforbindelser samt laegemidler indeholdende disse
FI883249A (fi) Menetelmä terapeuttisesti käyttökelpoisten 3-desmetyylimevalonihappojohdannaisten valmistamiseksi
DK421187D0 (da) Laegemiddel indeholdende dipyridamol eller mopidamol og o-acetylsalicylsyre eller fysiologisk acceptable salte deraf
ES2054919T3 (es) Acidos y esteres 4-(quinolin-2-il-metoxi)fenilaceticos alfa-substituidos en caso dado.
NO941677L (no) Tetrazolderivater av gallesyrer, fremgangsmåter for fremstilling og deres anvendelse som legemiddel
NO933647L (no) Karboksylsyrederivater, legemidler inneholdende disse og fremgangsmåte for deres fremstilling
NO941937D0 (no) Sakarinderivater som inhiberer proteolytiske enzymer
DE69232929D1 (de) Saccharinderivate als proteolytische Enzyminhibitoren
DE3785684D1 (de) Pyrrolidinamid-derivate von acylaminosaeure, pharmazeutische zusammensetzung und verwendung.
NO891940L (no) Fremgangsmaate for selektivt aa redusere permeabiliteten avoljefrie soner i underjordiske formasjoner.
MY131595A (en) Heterocyclically substituted phenyl-cyclohexane- carboxylic acid derivatives
FI915093A0 (fi) Sackarinderivat anvaendbara som inhibitorer foer proteolytiskt enzym och deras framstaellning.
DK553988A (da) 4-aminopyridin-derivater og farmaceutiske praeparater indeholdende disse
NO924921L (no) Polyaspartamidderivater som adsorbsjonsmiddel for gallesyrer, polyaspartamidderivat lastet med gallesyrer og fremgangsmaater for fremstilling av disse, samt deres anvendelse som legemiddel
DK20489D0 (da) 1-heterocyclyl-1h-indazol-3-eddikesyre-forbindelser og farmaceutiske praeparater indeholdende disse eller tilsvarende 1-phenyl-forbindelser
DK162600C (da) Oe4-(2-hydroxycyklohexylmethyl)phenylaaalkansyrederivater og fremgangsmaade til fremstilling deraf samt farmaceutiske midler indeholdende disse
DK433787D0 (da) 1-phenylquinazolin-1h,3h-2,4-dioner og 1-phenylpyrido oe2,3-daapyrimidin-1h,3h-dioner, estere og syreadditionssalte deraf samt farmaceutiske midler indeholdende saadanne forbindelser
DK712388A (da) Heterocyclisk substituerede oxo- eller thiophthalazinyl-eddikesyre-forbindelser og farmaceutiske praeparater indeholdende disse
ATE75399T1 (de) Therapeutikum zur behandlung von magengeschwueren.
NO842218L (no) Peptidderivater og anvendelse derav som substrater for kvantitativ bestemmelse av enzymer
DK245787D0 (da) Nicotinsyrederivater, fremgangsmaade til fremstilling deraf og praeparater med fungicid virkning indeholdende disse derivater
DK362288A (da) Homocyclostatin- og cyclostatinholdige peptider og farmaceutiske praeparater indeholdende disse
DK222886A (da) Propionylanilider, fremgangsmaade til fremstilling heraf og farmaceutiske praeparater indeholdende disse forbindelser

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment